Random Allocation: Clinical Trials

2 trials of Random Allocation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Random Allocation: new trials by email Literature Review of Random Allocation trials Research Report on Random Allocation

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
CTx-1301-Dexmethylphenidate 12.5 mg (titration only), CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose), CTx-1301-Dexmethylphenidate 25mg (randomized fixed dose) - ADHD, Attention Deficit Hyperactivity Disorder
Phase 3CompletedCingulate Therapeutics1032023-08-012026-01-22
Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison
isoniazid , randomized, open label, rifampin, randomized, open label - Tuberculosis
Phase 3CompletedNational Taiwan University Hospital23842008-01-012010-11-29

Conditions studied

Attention Deficit Disorder with Hyperactivity (1)  ·  Tuberculosis (1)

Sponsors

Cingulate Therapeutics (1)  ·  National Taiwan University Hospital (1)

Countries

Taiwan (1)  ·  United States (1)

Top investigators

Ann Childress, MD (1)  ·  Li-Min Huang, MD, PHD (1)  ·  Matt Brams, MD (1)

Results publications

PMID 22410137